文传商讯
CORRECTING and REPLACING KATE, Japan’s No. 1 Makeup Brand, Launches Strategic Initiatives to Streng
2025-07-15 16:11:38
Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narco
2025-07-15 16:11:38
IOVA截止日期:Rosen Law Firm敦促损失超过10万美元的Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)股东与
2025-07-15 16:11:38
CORRECTING and REPLACING KATE, Japan’s No. 1 Makeup Brand, Launches Strategic Initiatives to Streng
2025-07-15 15:50:06



